• LOGIN
Repository logo

BORIS Portal

Bern Open Repository and Information System

  • Publication
  • Projects
  • Funding
  • Research Data
  • Organizations
  • Researchers
  • LOGIN
Repository logo
Unibern.ch
  1. Home
  2. Publications
  3. Hepatitis B and C in Switzerland - healthcare provider initiated testing for chronic hepatitis B and C infection
 

Hepatitis B and C in Switzerland - healthcare provider initiated testing for chronic hepatitis B and C infection

Options
  • Details
BORIS DOI
10.7892/boris.53752
Date of Publication
May 17, 2013
Publication Type
Article
Division/Institute

Universitätsklinik fü...

Departement Klinische...

Author
Fretz, Rainer
Negro, Francesco
Bruggmann, Philip
Lavanchy, Daniel
De Gottardi, Andrea
Universitätsklinik für Viszerale Chirurgie und Medizin, Hepatologie
Pache, Isabelle
Masserey Spicher, Virginie
Cerny, Andreas
Departement Klinische Forschung, Forschungsgruppe Viszeralchirurgie
Subject(s)

600 - Technology::610...

Series
Swiss medical weekly
ISSN or ISBN (if monograph)
1424-7860
Publisher
EMH Schweizerischer Ärzteverlag
Language
English
Publisher DOI
10.4414/smw.2013.13793
PubMed ID
23740193
Description
Hepatitis B and hepatitis C are contagious liver diseases caused by the hepatitis B virus (HBV) and the hepatitis C virus (HCV), respectively. In particular, chronic infection with HBV or HCV is a major public health problem throughout Europe. The majority of persons chronically infected (65%-75%) are not aware of their infection status until symptoms of advanced liver disease appear. In addition, the peak in the number of patients suffering from advanced stages of the disease, such as cirrhosis and hepatocellular carcinoma, has not yet been reached. In order to reduce the current and future morbidity and mortality associated with chronic HBV or HCV infection, the timely detection of chronically infected persons, with follow-up and case management, is crucial. However, the current screening strategies in Europe and Switzerland have to be considered as inadequate to detect the majority of chronically infected persons. Hence, we emphasise the importance of an alternative approach: the healthcare provider initiated identification of HBV or HCV infection in defined risk groups. This entails determining whether a person is not only at risk of being chronically infected, but also at risk of becoming infected with HBV or HCV and, if necessary, testing for HBV or HCV infection.
Handle
https://boris-portal.unibe.ch/handle/20.500.12422/124262
Show full item
File(s)
FileFile TypeFormatSizeLicensePublisher/Copright statementContent
Hepatitis B and C in Switzerland – healthcare.pdftextAdobe PDF628.05 KBAttribution-NonCommercial-NoDerivatives (CC BY-NC-ND 4.0)publishedOpen
BORIS Portal
Bern Open Repository and Information System
Build: d1c7f7 [27.06. 13:56]
Explore
  • Projects
  • Funding
  • Publications
  • Research Data
  • Organizations
  • Researchers
More
  • About BORIS Portal
  • Send Feedback
  • Cookie settings
  • Service Policy
Follow us on
  • Mastodon
  • YouTube
  • LinkedIn
UniBe logo